Dr. Filosso on Future of Treating Patients With Lung NETs

Pier Luigi Filosso, MD
Published: Tuesday, Feb 16, 2016



Pier Luigi Filosso, MD, associate professor of Thoracic Surgery, University of Torino, Italy, discusses future approaches to treating patients with neuroendocrine tumors (NETs) of lung origin.

The backbone treatment for these patients will be surgery, Filosso explains. However, there needs to be new targeted therapies for patients with aggressive disease in terms of lymph node metastasis.

It is known that patients with low- and intermediate-risk tumors may develop recurrence or distant metastasis. Therefore, a strict clinical treatment plan needs to be developed for this population, Filosso adds.

SELECTED
LANGUAGE


Pier Luigi Filosso, MD, associate professor of Thoracic Surgery, University of Torino, Italy, discusses future approaches to treating patients with neuroendocrine tumors (NETs) of lung origin.

The backbone treatment for these patients will be surgery, Filosso explains. However, there needs to be new targeted therapies for patients with aggressive disease in terms of lymph node metastasis.

It is known that patients with low- and intermediate-risk tumors may develop recurrence or distant metastasis. Therefore, a strict clinical treatment plan needs to be developed for this population, Filosso adds.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: How to Use Liquid Biopsies Throughout the Lung Cancer Treatment Continuum OnlineJan 31, 20191.5
35th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® Clinical Vignette SeriesJan 31, 20192.0
Publication Bottom Border
Border Publication
x